Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study

Abroad (travel likely)RecruitingPHASE2

Conditions

Esophageal Squamous Cell Carcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Affiliated Hospital of Putian University, Putian, Fujian, China

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Efficacy and Safety of Adebrelimab Combined With Chemoradiotherapy in Patients With Unresectable Locally Advanced or Postoperative Recurrent Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Guangzhou, China

Intensive Nutritional Support in Conversion Therapy for Locally Advanced Unresectable ESCC

Esophageal Squamous Cell Carcinoma · Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Chengdu, China

A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC

Esophageal Squamous Cell Carcinoma · Ivonescimab · Neoadjuvant

Abroad (travel likely)RecruitingPHASE1, PHASE2

Xi'an, China

Efficacy and Safety of Neoadjuvant Envafolimab Combined With Albumin-bound Paclitaxel and Carboplatin for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma · Neoadjuvant Therapy

Abroad (travel likely)RecruitingPHASE2

Shanghai, China